Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$150 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$3 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
33.6
P/B Ratio
1.3
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
11,500,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LAVA Medtech Acquisition Corp (LVAC)
| 2.5 | 0.0 | 0.9 | 4.3 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LAVA Medtech Acquisition Corp (LVAC)
|
10.4 | 149.9 | 0.0 | 4.5 | -- | 4 | 33.6 | 1.3 |
| 10.3 | 201.9 | 0.0 | 1.0 | -- | 0.6 | -- | 0.0 | |
| 13.9 | 98.5 | 0.0 | -4.9 | -- | -3.7 | -- | 1.3 | |
| 26.2 | 79.0 | 0.0 | -8.6 | -- | -25.1 | -- | 0.0 | |
| 10.2 | 131.3 | 0.0 | 1.2 | -- | -3.7 | -- | 1.3 | |
| 8.3 | 86.6 | 0.0 | -3.6 | -- | -3.2 | -- | 1.3 | |
| 10.5 | 253.6 | 0.0 | 6.3 | -- | 3.3 | 95.8 | 0.0 | |
| 10.4 | 289.0 | 0.0 | 7.3 | -- | 3.3 | 41.6 | 1.3 | |
| 10.2 | 452.3 | 0.0 | 18.2 | -- | 5.4 | 93 | 1.3 | |
| 6.1 | 78.5 | 0.0 | 0.9 | -- | 1.4 | -- | 1.3 |
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or... more businesses. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Read more
CEO & Director
Dr. Anthony Natale M.B.A., M.D.
CEO & Director
Dr. Anthony Natale M.B.A., M.D.
Headquarters
Waltham, MA
Website
--
Our rating system has guided millions of investors in the past 20 years.
The share price of LAVA Medtech Acquisition Corp (LVAC) is $10.44 (NASDAQ) as of 19-May-2023 09:30 EDT. LAVA Medtech Acquisition Corp (LVAC) has given a return of 4.3% in the last 1 years.
The P/E ratio of LAVA Medtech Acquisition Corp (LVAC) is 33.65 times as on 19-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of LAVA Medtech Acquisition Corp (LVAC) are Rs -- and Rs -- as of 02-Apr-2026.
LAVA Medtech Acquisition Corp (LVAC) has a market capitalisation of $ 150 Mln as on 19-May-2023. As per SEBI classification, it is a Small Cap company.
Before investing in LAVA Medtech Acquisition Corp (LVAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.